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Abstract
Ultrasonography is the best available tool for the initial work-up of thyroid nodules. 
Substantial interobserver variability has been documented in the recognition and 
reporting of some of the lesion characteristics. A number of classification systems 
have been developed to estimate the likelihood of malignancy: several of them have 
been endorsed by scientific societies, but their reproducibility is yet to be assessed. We 
evaluated the interobserver variability of the AACE/ACE/AME, ACR, ATA, EU-TIRADS 
and K-TIRADS classification systems and the interobserver concordance in the indication 
to FNA biopsy. Two raters independently evaluated 1055 ultrasound images of thyroid 
nodules identified in 265 patients at multiple time points, in two separate sets (501 and 
554 images). After the first set of nodules, a joint reading was performed to reach a 
consensus in the feature definitions. The interobserver agreement (Krippendorff alpha) 
in the first set of nodules was 0.47, 0.49, 0.49, 0.61 and 0.53, for AACE/ACE/AME, ACR, 
ATA, EU-TIRADS and K-TIRADS systems, respectively. The agreement for the indication to 
biopsy was substantial to near-perfect, being 0.73, 0.61, 0.75, 0.68 and 0.82, respectively 
(Cohen’s kappa). For all systems, agreement on the nodules of the second set increased. 
Despite the wide variability in the description of single ultrasonographic features, the 
classification systems may improve the interobserver agreement that further ameliorates 
after a specific training. When selecting nodules to be submitted to FNA biopsy, that 
is main purpose of these classifications, the interobserver agreement is substantial to 
almost perfect.
Introduction
Thyroid nodules are an increasingly common finding 
during imaging examinations of the neck, but only a 
small proportion of these lesions ultimately prove to be 
malignant (1). Fine-needle aspiration (FNA) biopsy plays a 
major role the differential diagnosis, but its execution needs 
to be selective (2), due to the associated costs, potential 
non-diagnostic results (3), and the risk of overdiagnosis 
(4). Ultrasonography (US) is currently the best diagnostic 
tool available for the initial work-up of thyroid 
nodules. Certain US features are more or less strongly 
associated with nodule malignancy (5). However, the 
diagnostic accuracy of each single feature is limited, 
and substantial interobserver variation that has been 
documented in the recognition and reporting of some 
of the lesion characteristics. The low reproducibility of 
US classifications of thyroid nodules is aggravated by the 
heterogenous professional profiles and experience levels 
of the individuals who perform thyroid US scans (e.g., 
technicians, radiologists, clinicians) and interpret the 
results (6).
A number of classification systems have been 
developed that use composite patterns of US findings to 
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estimate the likelihood of malignancy and, in particular, 
to identify nodules that need to be scheduled for FNA 
biopsy (7, 8). Several of these systems have been endorsed 
by international scientific bodies (9, 10, 11, 12, 13), but 
their reproducibility is yet to be assessed.
We conducted a retrospective analysis of recorded 
US images to evaluate the interobserver variability in the 
application the main thyroid nodule US classification 
systems and the resulting interobserver concordance in 
the indication to perform FNA biopsy.
Subjects and methods
Cases
We conducted a retrospective analysis of 1055 ultrasound 
images of thyroid nodules identified in 265 patients 
(each with less than four nodules). All had originally 
been classified as benign (those with suspicious US 
features but benign cytology) or presumably benign 
(nodules with no suspicious ultrasound features) and 
managed with active surveillance as long as there was no 
evidence of malignancy. The images had been acquired 
in our thyroid cancer unit at the time of nodule detection 
and/or during the first five years thereafter and stored in 
order to precisely document the main nodule features 
over time. All examinations were performed by a single 
examiner, with 10-year experience in thyroid US, using 
an Esaote MyLab 25 (Esaote SpA, Genoa, Italy) ultrasound 
system with a high-frequency linear transducer. The 
cases included in the present study represent our center’s 
contribution to a larger multicenter cohort of patients 
analyzed prospectively to explore the natural history 
of benign thyroid nodules. The original study, which 
has been described in detail elsewhere, (14, 15) was 
conducted with Institutional Review Board (Sapienza 
University of Rome Ethics Committee) approval and the 
written informed consent of all participants. Between 
January 1, 2006, and January 31, 2008, centers enrolled 
a consecutive series of euthyroid patients presenting 
with one to four asymptomatic thyroid nodules, 
measuring 4–40 mm, that were presumed to be benign 
on the basis of a benign cytology report or the absence 
of suspicious sonographic features. Exclusion criteria 
were levothyroxine therapy during the study or in the 
6  months preceding enrollment, history of surgical or 
nonsurgical thyroid interventions, history of thyroid 
autoimmunity and subacute thyroiditis. Enrolled 
patients were followed with yearly clinical and US 
evaluations.
For the purposes of the present study, the images 
of the 1055 nodules (at various follow-up points) were 
converted to and stored as deidentified bitmap (BMP) 
files. The stored files were then randomly divided into two 
groups: set 1 (501 nodules) and set 2 (554 nodules).
Review of ultrasound images
Analysis of image set 1
The BMP file of each nodule in set 1 was independently 
reviewed on a single liquid crystal display monitor by 
two clinicians (GG and LL). Each reader had 6  years of 
experience in thyroid US imaging, although they had 
been trained in two different thyroid units. The readers 
were blinded to the identity of the patient, the date of the 
scan and all other clinical information regarding the case.
Using standardized in-house multiple-choice forms 
developed on the basis of published suggestions (6, 16), 
the two readers rated the following US features of each 
nodule: margins (well-defined, ill-defined, microlobulated 
or irregular, infiltrative, peripheral halo); composition 
(solid, cystic, mixed); echogenicity (hyperechoic, 
isoechoic, hypoechoic—all with respect to the surrounding 
thyroid parenchyma—or markedly hypoechoic, i.e., less 
echoic than the adjacent strap muscle); calcifications 
(absent, microscopic, macroscopic—the latter including 
eggshell calcifications); other hyperechoic foci (comet-
tail artifacts or indeterminate, the latter including areas 
of fibrosis). For mixed-content nodules, the reader also 
rated the location of the solid component (diffuse-
not nodular, peripheral, central), and recorded the 
spongiform appearance. Echogenicity and structure were 
not evaluated in nodules with complete rim calcification. 
Three other parameters were not rated by either of the 
readers: (1) nodule diameters (transverse, anteroposterior 
and longitudinal), which had been recorded during the 
original scan and were visible on the stored images; 
(2) nodule shape, parallel or non-parallel (or taller-than-
wide), the classification of which is strictly dependent 
on the nodule dimensions and (3) vascularity, because it 
was not available in all of the cases. These features were 
excluded from analyses of interobserver agreement.
For each nodule, the ratings of each reader (together 
with those recorded during the original examination for 
nodule size and shape) were elaborated automatically 
using an in-house algorithm to classify the nodule 
according to the following five systems: Guidelines of 
the American Association of Clinical Endocrinologists/
American College of Endocrinology/Associazione Medici 
Endocrinologi (AACE/ACE/AME) (9); the TIRADS system 
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developed by the American College of Radiologists 
(ACR) (10); the 2015 Guidelines of the American Thyroid 
Association (ATA) (11); the EU-TIRADS system proposed 
by the European Thyroid Association (12) and the Korean 
Society of Thyroid Radiology’s K-TIRADS system (13).
Training session
Two weeks after their independent reviews and classification 
of set 1 images, the two readers jointly reviewed the results 
and the images of all 501 nodules. Discrepancies between 
their ratings were discussed and a consensus decision 
reached for each nodule feature. The consensus ratings 
were then elaborated using the same algorithm to generate 
new risk classifications of the nodules for each system.
Analysis of image set 2
Four weeks after completion of the training session, 
the two readers were asked to independently review US 
images of the 554 nodules of set 2 and to rate them using 
the same methods employed for set 1. The results were 
automatically elaborated to obtain risk classifications 
for each nodule according to the same five systems.
Analysis of data
For each set of nodules, we assessed inter-reader agreement 
at the level of single features of the nodule, risk-class 
assignment based on each of the five US classification 
systems and the advisability/non-advisability of FNA 
biopsy based on the risk-class assignments. Agreement 
on ordinal ratings was assessed with the Krippendorff α 
statistic (17). Values close to 1 indicate high inter-reader 
agreement, and values above 0.65 are considered an 
acceptable basis for tentative conclusions. Interobserver 
agreement on nominal, dichotomic ratings was evaluated 
using Cohen’s kappa statistic. Values less than 0.20 are 
considered indicative of slight agreement; 0.21–0.40, fair 
agreement; 0.41–0.60, moderate agreement; 0.61–0.80, 
substantial agreement and 0.81–1.00, near-perfect 
agreement (18). For all statistics, 95% confidence intervals 
(CI) were also calculated. All analyses were performed 
with IBM SPSS Statistics program, v. 23.0 (IBM).
Results
Supplementary Table 1 (see section on supplementary data 
given at the end of this article) shows the estimated risks 
of malignancy for set 1 and set 2 nodules, respectively, 
based on the consensus judgments of the two readers. 
(These data are presented for informative purposes only. 
All of the analyses presented below were restricted to 
assessment of agreement between the independent ratings 
of the readers in their descriptions of the nodules.)
Table  1 shows the interobserver agreement for the 
recognition of single US features in set 1 and set 2, as well as 
those reported in previous studies of this type (19, 20, 21, 
22, 23, 24, 25, 26, 27, 28). Agreement between the readers 
in our study was highest regarding the presence/absence 
of calcifications (particularly macrocalcifications). Alpha 
values for single features in the second set of nodules were 
not significantly different from those for set 1.
Table  2 summarizes the data on interobserver 
agreement nodule risk classification for the five reporting 
systems tested. For each nodule set, results are presented 
for all lesions and for the subset of lesions exceeding 
1 cm in diameter. For all five systems, agreement on the 
nodules of set 2 was appreciably better than that recorded 
for the set 1. This effect was independent of nodule size, 
but the degree of improvement varied from system to 
system. In all of the comparisons, classification according 
to the EU-TIRADS system displayed the highest level of 
reproducibility.
As shown in Table 3, agreement in the identification of 
set 1 nodules that required FNA biopsy according to the five 
systems was already substantial to near-perfect. Nevertheless, 
the Cohen kappas for the second set of nodules were 
consistently higher for all five classifications systems.
Discussion
Several classification systems have been developed to 
help physicians decide which of the myriad thyroid 
nodules discovered each year need to be evaluated 
with FNA biopsy. These efforts were motivated by the 
conviction that defining the risk of malignancy based 
on the presence/absence of composite sets of US features 
would reduce the interobserver variability seen when 
risk estimates were based on the presence/absence of 
individual features. However, all are heavily dependent 
on the operator’s ability to accurately describe key nodule 
features, such as composition or echogenicity (30), which, 
in previous studies, have been characterized by suboptimal 
interobserver agreement (28, 31). The aim of the present 
study was evaluating the interobserver reliability in the 
application of the main thyroid nodule US classification 
systems. Few attempts have been made to demonstrate 
whether or not these systems do allow a more reproducible 
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stratification of thyroid nodules. On the basis of the data 
collected in the present study, the answer appears to be 
‘yes.’ On the whole, classification of thyroid nodules using 
any of the five systems we tested is associated with higher 
interobserver agreement than classification based on 
single suspicious features, although there is clearly room 
for further improvement. More importantly, identification 
of nodules that require FNA biopsy based on these 
classification systems, which is in fact their main purpose, 
is associated with substantial to near-perfect agreement.
Other factors, aside from the experience in general 
thyroid imaging and nodule size, should be taken into 
account when working to improve reliability of standard 
US reporting of thyroid nodules. Several approaches 
have already been proposed to achieve this target, such 
as quantitative evaluation of echogenicity (31) and more 
systematic reporting schemas. (6, 12, 32).
A specific ‘hands-on’ training involving joint reading 
of US images can improve the reproducibility of all the 
risk classifications, even for trained readers with similar 
levels of experience, with significant improvements 
for ATA, K-TIRADS and EU-TIRADS systems, even if no 
significant difference is recorded for any single variable. 
Some of the classification systems place substantial 
weight on certain individual features (in most cases, solid 
structure and hypoechogenicity), and the reproducibility 
of these classifications depends on the agreement between 
readers in describing these particular features. However, 
the weight of each feature varies across various systems 
(echogenicity being, for example, the most important 
Table 1 Interobserver agreement for single US features, compared with published data.
   
This study
 
Choi, 2010 (22)a
 
Kim, 2012 (23)
 
Kim, 2010 (24)a
Koltin, 2016 
(25)
Lim-Dunham, 
2017 (26)
Norlen, 2014 
(32)b
 
Park, 2009 (27)
 
Park, 2010 (28)
 
Park, 2012 (29)
 
Wienke, 2003 (30)
 
Grani, 2017 (31)
Nodules Set 1: 501 Set 2: 554 204 80 133 27 (pediatric 
pop.)
39 (pediatric 
population)
141 (AUS/
FLUS)
52 (all 
malignant)
133 400 70 49 (AUS/FLUS/FN)
Statistics Krippendorff alpha Kappa Kappa Kappa Kappa Kappa Kappa Spearman 
corr.
Kappa Kappa Kappa Krippendorff 
alpha
Observers 2 clinicians, same level of experience 4 exp. radiologists, 
same institution
7 resident 
radiologists, 
2 different 
units
9 5 faculty 
radiologists
4 residents 3 exp. 
radiologists
2 exp. 
radiologists
2 trained 
surgeons
3 radiologists 
(1–7 year 
exp.)
5 radiologists 
(1-–6 6 year 
exp.)
3 radiologists 
(7-–10 
10 year 
exp.), 
different 
institution
2 radiologists 3 clinicians, 2 
different units
Echogenicity 0.56 (0.46-–0.66) 0.66 (0.59-–0.73) 0.45 0.5 0.46 0.57 0.34 0.46 0.54 (0.37-–0.73) 0.94 0.04–0.45 0.57 0.504 0.37 0.58 (0.45–0.70)
Composition 0.52 (0.34–0.68) 0.5 (0.29–0.68) 0.59 0.48 0.36 0.64 0.18 N/A 0.8 (0.53–0.99) N/A 0.70–1.00 0.64 0.818 0.62 0.5 (0.29–0.68)
Shape N/A N/A 0.61 0.57 0.4 0.46 0.34 N/A 0.29 (0.01–0.72) 0.61 0.48–0.79 0.42 0.42 N/A N/A
Margin 0.51 (0.43–0.58) 0.44 (0.34–0.53) 0.61 0.49 0.25 0.4 0.19 0.58 0.6 (0.4–0.79) 0.6 0.03–0.29 0.34 0.33 0.13 0.57 (0.43–0.70)
Vascularity N/A N/A 0.46 N/A N/A N/A N/A 0.18 0.76 (0.52–0.99) 0.74 N/A N/A N/A 0.75 N/A
Calcification 0.8 (0.63–0.93) 0.89 (0.75–1) 0.58 0.62 0.47 0.63 0.42 N/A N/A N/A 0.47–0.62 0.55 0.479 0.91 0.68 (0.46–0.88)
Micro- 0.49 (−0.28–1) 0.39 (−0.49–1) 0.51 0.59 N/A N/A N/A 0.59 N/A 0.79 N/A 0.54 N/A N/A N/A
Macro- 0.85 (0.59–1) 0.83 (0.6–1) 0.39 0.39 N/A N/A N/A N/A N/A N/A N/A 0.4 N/A N/A N/A
Echogenic foci 0.48 (0.3–0.64) 0.35 (0.17–0.52) N/A N/A N/A N/A N/A N/A 0.77 (0.56–0.99) N/A N/A N/A N/A N/A 0.34 (0.12–0.56)
Capsule invasion 0.11 (−0.91–1) 0.4 (−1–1) N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.32 N/A N/A 0.32 (–0.61–1.0)
aMaximum k value reported in any of the two sessions; bAll features were grouped in two classes.
AUS/FLUS, Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance; FN, Follicular Neoplasm; N/A, not available.
Table 2 Interobserver agreement for nodule classification the various US classification systems endorsed by scientific societies.
  All nodules Only nodules >1 cm
Set 1 (n = 501) Set 2 (n = 554) Set 1 (n = 219) Set 2 (n = 207)
AACE/ACE/AME 0.47 (0.35–0.57) 0.61 (0.49–0.72) 0.53 (0.41–0.63) 0.58 (0.44–0.71)
ACR TIRADS 0.49 (0.4–0.57) 0.57 (0.5–0.63) 0.45 (0.31–0.58) 0.62 (0.51–0.71)
ATA 0.49 (0.41–0.57) 0.65 (0.58–0.71) 0.44 (0.3–0.56) 0.72 (0.62–0.81)
EU-TIRADS 0.61 (0.54–0.68) 0.75 (0.69–0.81) 0.63 (0.52–0.72) 0.77 (0.71–0.83)
K-TIRADS 0.53 (0.43–0.62) 0.66 (0.57–0.73) 0.54 (0.43–0.66) 0.74 (0.6–0.86)
Krippendorff alpha (95% CI).
AACE/ACE/AME, American Association of Clinical Endocrinologists/American College of Endocrinology/Associazione Medici Endocrinologi; ACR, American 
College of Radiologists; ATA, American Thyroid Association; EU-TIRADS, European Thyroid Imaging Reporting and Data Systems; K-TIRADS, Korean 
Thyroid Imaging Reporting and Data Systems.
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one for EU-TIRADS, and composition for K-TIRADS). 
Furthermore, the precise identification of the full range 
of possible descriptions is not needed for classification: 
for example, only irregular or infiltrative margins impact 
the nodule classification, while the difference between 
regular, ill-defined and hypoechoic halo is negligible. 
The differences in the system structure may also explain 
the higher interobserver agreement for some systems. 
Classifications with a lower number of high-suspicious 
features and more gradual scoring show better interobserver 
reliability (such as EU-TIRADS) than the ones in which a 
single description may dramatically change the nodule 
classification (ACR TIRADS, ATA guidelines). Similarly, 
the agreement on the FNA biopsy indication is influenced 
by the philosophy behind each classification: K-TIRADS 
system has the highest reproducibility because the vast 
majority of low- and intermediate-suspicion nodules are 
submitted to FNA biopsy according to the Korean system, 
while the other classification are more conservative, 
with higher dimensional cutoff and deeper management 
differences between low- and intermediate-suspicion 
categories – that represent a source of variability.
These findings are similar to that reported by Cheng 
for the first TIRADS ever proposed (k = 0.61, moderate to 
substantial agreement) (33), although in other hands, 
the agreement observed with this system was appreciably 
lower (k = 0.27) (34). Our group reported, in a previous 
study (28), a suboptimal agreement in a small series 
of cytologically indeterminate nodules (Krippendorff 
alpha 0.36 for ATA classification and 0.42 for TIRADS 
classification proposed by Kwak (35)). An even higher k 
value of 0.72 was reported by Russ and coworkers for the 
system they proposed in 2013 (36), which is the basis of the 
current EU-TIRADS systems. According to some evidence, 
thyroid computer-aided diagnosis (CAD) using artificial 
intelligence may further improve diagnosis reliability. It 
was reported that the use of thyroid CAD to differentiate 
malignant from benign nodules showed accuracy similar 
to that obtained by radiologists (37, 38) and may reduce 
intra- and interobserver variability.
Our study has some obvious limitations. First, owing 
to its retrospective nature, it was not possible to consider 
Table 1 Interobserver agreement for single US features, compared with published data.
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radiologists
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radiologists
2 trained 
surgeons
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(1–7 year 
exp.)
5 radiologists 
(1-–6 6 year 
exp.)
3 radiologists 
(7-–10 
10 year 
exp.), 
different 
institution
2 radiologists 3 clinicians, 2 
different units
Echogenicity 0.56 (0.46-–0.66) 0.66 (0.59-–0.73) 0.45 0.5 0.46 0.57 0.34 0.46 0.54 (0.37-–0.73) 0.94 0.04–0.45 0.57 0.504 0.37 0.58 (0.45–0.70)
Composition 0.52 (0.34–0.68) 0.5 (0.29–0.68) 0.59 0.48 0.36 0.64 0.18 N/A 0.8 (0.53–0.99) N/A 0.70–1.00 0.64 0.818 0.62 0.5 (0.29–0.68)
Shape N/A N/A 0.61 0.57 0.4 0.46 0.34 N/A 0.29 (0.01–0.72) 0.61 0.48–0.79 0.42 0.42 N/A N/A
Margin 0.51 (0.43–0.58) 0.44 (0.34–0.53) 0.61 0.49 0.25 0.4 0.19 0.58 0.6 (0.4–0.79) 0.6 0.03–0.29 0.34 0.33 0.13 0.57 (0.43–0.70)
Vascularity N/A N/A 0.46 N/A N/A N/A N/A 0.18 0.76 (0.52–0.99) 0.74 N/A N/A N/A 0.75 N/A
Calcification 0.8 (0.63–0.93) 0.89 (0.75–1) 0.58 0.62 0.47 0.63 0.42 N/A N/A N/A 0.47–0.62 0.55 0.479 0.91 0.68 (0.46–0.88)
Micro- 0.49 (−0.28–1) 0.39 (−0.49–1) 0.51 0.59 N/A N/A N/A 0.59 N/A 0.79 N/A 0.54 N/A N/A N/A
Macro- 0.85 (0.59–1) 0.83 (0.6–1) 0.39 0.39 N/A N/A N/A N/A N/A N/A N/A 0.4 N/A N/A N/A
Echogenic foci 0.48 (0.3–0.64) 0.35 (0.17–0.52) N/A N/A N/A N/A N/A N/A 0.77 (0.56–0.99) N/A N/A N/A N/A N/A 0.34 (0.12–0.56)
Capsule invasion 0.11 (−0.91–1) 0.4 (−1–1) N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.32 N/A N/A 0.32 (–0.61–1.0)
aMaximum k value reported in any of the two sessions; bAll features were grouped in two classes.
AUS/FLUS, Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance; FN, Follicular Neoplasm; N/A, not available.
Table 3 Interobserver agreementa on indications for FNA 
biopsy according to the various guidelines.
 Set 1 (n = 501) Set 2 (n = 554)
AACE/ACE/AME 0.73 (0.64–0.82) 0.82 (0.75–0.89)
ACR TIRADS 0.61 (0.5–0.72) 0.73 (0.63–0.82)
ATA 0.75 (0.67–0.82) 0.82 (0.75–0.89)
EU-TIRADS 0.68 (0.58–0.79) 0.74 (0.65–0.83)
K-TIRADS 0.82 (0.76–0.88) 0.91 (0.86–0.95)
aCohen kappa (95% confidence intervals).
AACE/ACE/AME, American Association of Clinical Endocrinologists/
American College of Endocrinology/Associazione Medici Endocrinologi; 
ACR, American College of Radiologists; ATA, American Thyroid 
Association; EU-TIRADS, European Thyroid Imaging Reporting and Data 
Systems; K-TIRADS, Korean Thyroid Imaging Reporting and Data Systems.
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the influence on interobserver agreement of scan-related 
variables, such as probe inclination, US equipment used, 
operating conditions and setting. Second, the sample 
consisted exclusively of nodules that had initially been 
classified as benign. This could potentially overestimate 
the agreement. However, all categories are represented in 
this series, and the sample size is broader than that in other 
non-selected series. Third, the readers involved in this study 
were ‘peers’ in terms of experience as well as staff members 
of in the same thyroid cancer unit, both of which factors 
could conceivably have contributed to the improved 
interobserver agreement we observed after the training 
session. Similar initiatives in larger, more heterogeneous 
groups might not have the same results. Furthermore, 
this study does not provide data about increasingly used 
ancillary techniques, like elastosonography (39, 40).
In conclusion, despite the wide variability in the 
description of single US features, the US classification 
systems may improve the interobserver agreement, 
that further ameliorates after a specific training. When 
selecting nodules to be submitted to FNA biopsy, that is 
main purpose of these classifications, the interobserver 
agreement is substantial to almost perfect.
Supplementary data
This is linked to the online version of the paper at https://doi.org/10.1530/
EC-17-0336.
Declaration of interest
The authors declare that there is no conflict of interest that could be 
perceived as prejudicing the impartiality of the research reported.
Funding
This research did not receive any specific grant from any funding agency in 
the public, commercial or not-for-profit sector.
Acknowledgements
G G and L L contributed to this paper as recipient of the PhD program of 
Biotechnologies and Clinical Medicine of the University of Rome, Sapienza. 
Writing support was provided by Marian Everett Kent, BSN.
References
 1 Filetti S, Durante C & Torlontano M. Nonsurgical approaches 
to the management of thyroid nodules. Nature Clinical Practice: 
Endocrinology and Metabolism 2006 2 384–394. (https://doi.
org/10.1038/ncpendmet0215)
 2 Lamartina L, Deandreis D, Durante C & Filetti S. ENDOCRINE 
TUMOURS: imaging in the follow-up of differentiated thyroid 
cancer: current evidence and future perspectives for a risk-adapted 
approach. European Journal of Endocrinology 2016 175 R185–R202. 
(https://doi.org/10.1530/EJE-16-0088)
 3 Grani G, Calvanese A, Carbotta G, D’Alessandri M, Nesca A, 
Bianchini M, Del Sordo M & Fumarola A. Intrinsic factors affecting 
adequacy of thyroid nodule fine-needle aspiration cytology. Clinical 
Endocrinology 2013 78 141–144. (https://doi.org/10.1111/j.1365-
2265.2012.04507.x)
 4 Brito JP, Morris JC & Montori VM. Thyroid cancer: zealous imaging 
has increased detection and treatment of low risk tumours. BMJ 2013 
347 f4706. (https://doi.org/10.1136/bmj.f4706)
 5 Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, 
Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, et al. The accuracy of 
thyroid nodule ultrasound to predict thyroid cancer: systematic review 
and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2014 
99 1253–1263. (https://doi.org/10.1210/jc.2013-2928)
 6 Su HK, Dos Reis LL, Lupo MA, Milas M, Orloff LA, Langer JE, 
Brett EM, Kazam E, Lee SL, Minkowitz G, et al. Striving toward 
standardization of reporting of ultrasound features of thyroid 
nodules and lymph nodes: a multidisciplinary consensus 
statement. Thyroid 2014 24 1341–1349. (https://doi.org/10.1089/
thy.2014.0110)
 7 Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A & 
Dominguez M. An ultrasonogram reporting system for thyroid 
nodules stratifying cancer risk for clinical management. Journal of 
Clinical Endocrinology and Metabolism 2009 94 1748–1751. (https://
doi.org/10.1210/jc.2008-1724)
 8 Ozel A, Erturk SM, Ercan A, Yılmaz B, Basak T, Cantisani V, 
Basak M & Karpat Z. The diagnostic efficiency of ultrasound in 
characterization for thyroid nodules: how many criteria are required 
to predict malignancy? Medical Ultrasonography 2012 14 24–28.
 9 Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, 
Paschke R, Valcavi R & Vitti P.  American Association of Clinical 
Endocrinologists, American College of Endocrinology, and 
Associazione Medici Endocrinologi medical guidelines for clinical 
practice for the diagnosis and management of thyroid nodules 
– 2016 update. Endocrine Practice 2016 22 622–639. (https://doi.
org/10.4158/EP161208.GL)
 10 Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, 
Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, et al. ACR 
thyroid imaging, reporting and data system (TI-RADS): white 
paper of the ACR TI-RADS committee. Journal of the American 
College of Radiology 2017 14 587–595. (https://doi.org/10.1016/j.
jacr.2017.01.046)
 11 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, 
Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, 
et al. 2015 American Thyroid Association Management Guidelines 
for adult patients with thyroid nodules and differentiated thyroid 
cancer: the American Thyroid Association Guidelines task force on 
thyroid nodules and differentiated thyroid cancer. Thyroid 2016 26 
1–133. (https://doi.org/10.1089/thy.2015.0020)
 12 Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R & Leenhardt L. 
European Thyroid Association Guidelines for ultrasound 
malignancy risk stratification of thyroid nodules in adults: the 
EU-TIRADS. European Thyroid Journal 2017 6 225–237. (https://doi.
org/10.1159/000478927)
 13 Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, Lim HK, 
Moon WJ, Na DG, Park JS, et al. Ultrasonography diagnosis 
and imaging-based management of thyroid nodules: revised 
Korean Society of thyroid radiology consensus statement and 
recommendations. Korean Journal of Radiology 2016 17 370–395. 
(https://doi.org/10.3348/kjr.2016.17.3.370)
 14 Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, 
Paciaroni A, Puxeddu E, Torlontano M, Tumino S, Attard M, et al. 
The natural history of benign thyroid nodules. JAMA 2015 313 
926–935. (https://doi.org/10.1001/jama.2015.0956)
 15 Grani G, Bruno R, Lucisano G, Costante G, Meringolo D, 
Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L,  
et al. Temporal changes in thyroid nodule volume: lack of effect 
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
https://doi.org/10.1530/EC-17-0336
http://www.endocrineconnections.org © 2018 The authors
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 12/27/2018 03:52:07PM
via Sapienza Universita di Roma and Universita Delgi Studi di Roma
G Grani et al. TIRADS interobserver variability 77:1
on paranodular thyroid tissue volume. Thyroid 2017 27  
1378–1384. (https://doi.org/10.1089/thy.2017.0201)
 16 Grant EG, Tessler FN, Hoang JK, Langer JE, Beland MD, Berland LL, 
Cronan JJ, Desser TS, Frates MC, Hamper UM, et al. Thyroid 
ultrasound reporting Lexicon: white paper of the ACR thyroid 
imaging, reporting and data system (TIRADS) committee. Journal 
of the American College of Radiology 2015 12 1272–1279. (https://
doi.org/10.1016/j.jacr.2015.07.011)
 17 Hayes AF & Krippendorff K. Answering the call for a 
standard reliability measure for coding data. Communication 
Methods and Measures 2007 1 77–89. (https://doi.
org/10.1080/19312450709336664)
 18 Landis JR & Koch GG. The measurement of observer agreement 
for categorical data. Biometrics 1977 33 159–174. (https://doi.
org/10.2307/2529310)
 19 Choi SH, Kim EK, Kwak JY, Kim MJ & Son EJ. Interobserver and 
intraobserver variations in ultrasound assessment of thyroid 
nodules. Thyroid 2010 20 167–172. (https://doi.org/10.1089/
thy.2008.0354)
 20 Kim HG, Kwak JY, Kim EK, Choi SH & Moon HJ. Man to man 
training: can it help improve the diagnostic performances and 
interobserver variabilities of thyroid ultrasonography in residents? 
European Journal of Radiology 2012 81 e352–e356. (https://doi.
org/10.1016/j.ejrad.2011.11.011)
 21 Kim SH, Park CS, Jung SL, Kang BJ, Kim JY, Choi JJ, Kim YI, Oh JK, 
Oh JS, Kim H, et al. Observer variability and the performance 
between faculties and residents: US criteria for benign and malignant 
thyroid nodules. Korean Journal of Radiology 2010 11 149–155. 
(https://doi.org/10.3348/kjr.2010.11.2.149)
 22 Koltin D, O’Gorman CS, Murphy A, Ngan B, Daneman A, 
Navarro OM, Garcia C, Atenafu EG, Wasserman JD, Hamilton J, et 
al. Pediatric thyroid nodules: ultrasonographic characteristics and 
inter-observer variability in prediction of malignancy. Journal of 
Pediatric Endocrinology and Metabolism 2016 29 789–794. (https://doi.
org/10.1515/jpem-2015-0242)
 23 Lim-Dunham JE, Erdem Toslak I, Alsabban K, Aziz A, Martin B, 
Okur G & Longo KC. Ultrasound risk stratification for malignancy 
using the 2015 American Thyroid Association Management 
Guidelines for children with thyroid nodules and differentiated 
thyroid cancer. Pediatric Radiology 2017 47 429–436. (https://doi.
org/10.1007/s00247-017-3780-6)
 24 Park SH, Kim SJ, Kim EK, Kim MJ, Son EJ & Kwak JY. Interobserver 
agreement in assessing the sonographic and elastographic features 
of malignant thyroid nodules. American Journal of Roentgenology 2009 
193 W416–W423. (https://doi.org/10.2214/AJR.09.2541)
 25 Park CS, Kim SH, Jung SL, Kang BJ, Kim JY, Choi JJ, Sung MS, 
Yim HW & Jeong SH. Observer variability in the sonographic 
evaluation of thyroid nodules. Journal of Clinical Ultrasound 2010 38 
287–293. (https://doi.org/10.1002/jcu.20689)
 26 Park SJ, Park SH, Choi YJ, Kim DW, Son EJ, Lee HS, Yoon JH, Kim EK, 
Moon HJ & Kwak JY. Interobserver variability and diagnostic 
performance in US assessment of thyroid nodule according to 
size. Ultraschall in Der Medizin 2012 33 E186–E190. (https://doi.
org/10.1055/s-0032-1325404)
 27 Wienke JR, Chong WK, Fielding JR, Zou KH & Mittelstaedt CA. 
Sonographic features of benign thyroid nodules: interobserver 
reliability and overlap with malignancy. Journal of Ultrasound 
in Medicine 2003 22 1027–1031. (https://doi.org/10.7863/
jum.2003.22.10.1027)
 28 Grani G, Lamartina L, Ascoli V, Bosco D, Nardi F, D’Ambrosio F, 
Rubini A, Giacomelli L, Biffoni M, Filetti S, et al. Ultrasonography 
scoring systems can rule out malignancy in cytologically 
indeterminate thyroid nodules. Endocrine 2017 57 256–261. (https://
doi.org/10.1007/s12020-016-1148-6)
 29 Norlen O, Popadich A, Kruijff S, Gill AJ, Sarkis LM, Delbridge L, 
Sywak M & Sidhu S. Bethesda III thyroid nodules: the role of 
ultrasound in clinical decision making. Annals of Surgical Oncology 
2014 21 3528–3533. (https://doi.org/10.1245/s10434-014-3749-8)
 30 Na DG, Baek JH, Sung JY, Kim JH, Kim JK, Choi YJ & Seo H. Thyroid 
imaging reporting and data system risk stratification of thyroid 
nodules: categorization based on solidity and echogenicity. Thyroid 
2016 26 562–572. (https://doi.org/10.1089/thy.2015.0460)
 31 Grani G, D’Alessandri M, Carbotta G, Nesca A, Del Sordo M, 
Alessandrini S, Coccaro C, Rendina R, Bianchini M, Prinzi N, et al. 
Grey-scale analysis improves the ultrasonographic evaluation of 
thyroid nodules. Medicine 2015 94 e1129. (https://doi.org/10.1097/
MD.0000000000001129)
 32 Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, 
Rago T & Russ G. 2013 European Thyroid Association Guidelines 
for cervical ultrasound scan and ultrasound-guided techniques 
in the postoperative management of patients with thyroid 
cancer. European Thyroid Journal 2013 2 147–159. (https://doi.
org/10.1159/000354537)
 33 Cheng SP, Lee JJ, Lin JL, Chuang SM, Chien MN & Liu CL. 
Characterization of thyroid nodules using the proposed thyroid 
imaging reporting and data system (TI-RADS). Head and Neck 2013 
35 541–547. (https://doi.org/10.1002/hed.22985)
 34 Friedrich-Rust M, Meyer G, Dauth N, Berner C, Bogdanou D, 
Herrmann E, Zeuzem S & Bojunga J. Interobserver agreement of 
Thyroid Imaging Reporting and Data System (TIRADS) and strain 
elastography for the assessment of thyroid nodules. PLoS ONE 2013 8 
e77927. (https://doi.org/10.1371/journal.pone.0077927)
 35 Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, Jung HK, 
Choi JS, Kim BM & Kim EK. Thyroid imaging reporting and data 
system for US features of nodules: a step in establishing better 
stratification of cancer risk. Radiology 2011 260 892–899. (https://doi.
org/10.1148/radiol.11110206)
 36 Russ G, Royer B, Bigorgne C, Rouxel A, Bienvenu-Perrard M & 
Leenhardt L. Prospective evaluation of thyroid imaging reporting 
and data system on 4550 nodules with and without elastography. 
European Journal of Endocrinology 2013 168 649–655. (https://doi.
org/10.1530/EJE-12-0936)
 37 Chang Y, Paul AK, Kim N, Baek JH, Choi YJ, Ha EJ, Lee KD, Lee HS 
& Shin D. Computer-aided diagnosis for classifying benign 
versus malignant thyroid nodules based on ultrasound images: a 
comparison with radiologist-based assessments. Medical Physics 2016 
43 554. (https://doi.org/10.1118/1.4939060)
 38 Choi YJ, Baek JH, Park HS, Shim WH, Kim TY, Shong YK & Lee JH. A 
computer-aided diagnosis system using artificial intelligence for the 
diagnosis and characterization of thyroid nodules on ultrasound: 
initial clinical assessment. Thyroid 2017 27 546–552. (https://doi.
org/10.1089/thy.2016.0372)
 39 Cantisani V, Grazhdani H, Drakonaki E, D’Andrea V, Di Segni M, 
Kaleshi E, Calliada F, Catalano C, Redler A, Brunese L, et al. Strain US 
elastography for the characterization of thyroid nodules: advantages 
and limitation. International Journal of Endocrinology 2015 2015 
908575. (https://doi.org/10.1155/2015/908575)
 40 Cosgrove D, Barr R, Bojunga J, Cantisani V, Chammas MC, 
Dighe M, Vinayak S, Xu JM & Dietrich CF. WFUMB guidelines and 
recommendations on the clinical use of ultrasound elastography: 
part 4. Thyroid. Ultrasound in Medicine and Biology 2017 43 4–26. 
(https://doi.org/10.1016/j.ultrasmedbio.2016.06.022)
Received in final form 4 November 2017
Accepted 9 November 2017
Accepted preprint published online 13 November 2017
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
https://doi.org/10.1530/EC-17-0336
http://www.endocrineconnections.org © 2018 The authors
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 12/27/2018 03:52:07PM
via Sapienza Universita di Roma and Universita Delgi Studi di Roma
